IPMCL-28b
IPMCL-28b is an antibacterial agent targeting the bacterial cell membrane. Its minimum inhibitory concentration (MIC) against Staphylococcus aureus ATCC 25923 is 1.56 μg/mL, and the MIC against methicillin-resistant Staphylococcus aureus (MRSA) is 6.25 μg/mL. IPMCL-28b is expected to be used in the research of the anti-infection field[1].
Product Specifications
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CCN(C(C5=CC=C(C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(NCCCCCCCCC)=O)=O)=O)=O)C=C5)=O)CC4)=C3)C1=O)O
Molecular Formula
C52H77FN12O8
Molecular Weight
1017.24
References & Citations
[1]Wen Q, et al. Naturally inspired chimeric quinolone derivatives to reverse bacterial drug resistance. Eur J Med Chem. 2025 May 5;289:117496.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 (ICAM-3) (186-2G9), CF594 conjugate, 0.1mg/mL
CD106 / VCAM1 (B-K9), CF568 conjugate, 0.1mg/mL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF740 conjugate, 0.1mg/mL
